Dear Colleagues,

 

I wanted to share with you the news that Cytisine has been added to WHO’s Essential Medicines List to help fight nicotine addiction.

 

A number of SRNT member researchers submitted letters in support of this addition. The Executive Summary of the “Report of the 25th WHO Expert Committee on Selection and Use of Essential Medicines” report can be found HERE.

 

The following is the statement on Cytisine from the Report: 

 

The Expert Committee recommended the inclusion of cytisine (INN cytisinicline) on the core list of the EML for use as an aid to stopping smoking and tobacco use, based on a favourable balance of benefits and harms, in an area of major public health need. The Committee considered that the availability of different smoking cessation treatments serves to provide valuable options and choice for patients and clinicians, could facilitate market competition, reduce costs and improve access to effective smoking and tobacco cessation treatments for national health systems.

 

For more information on this important subject, you may view a press release prepared by the Action on Smoking and Health (ASH).

 

Thank you to Dr. Nancy Rigotti for informing us of this important advance and thank you to all who submitted letters for this initiative to help improve health and save more lives!

 

Sincerely,

Christie Fowler

SRNT President

 
Society for Research on Nicotine & Tobacco | Website